An international study to assess reliability of the Migraine Disability Assessment (MIDAS) score

被引:453
|
作者
Stewart, WF
Lipton, RB
Whyte, J
Dowson, A
Kolodner, K
Liberman, JN
Sawyer, J
机构
[1] Innovat Med Res, Towson, MD USA
[2] Johns Hopkins Sch Publ Hlth, Baltimore, MD USA
[3] Albert Einstein Coll Med, Dept Neurol, Bronx, NY 10467 USA
[4] Albert Einstein Coll Med, Dept Epidemiol, Bronx, NY 10467 USA
[5] Albert Einstein Coll Med, Dept Social Med, Bronx, NY 10467 USA
[6] Zeneca Pharmaceut, Alderley Pk, England
[7] Kings Coll Hosp London, London, England
关键词
migraine disability; headache pain severity;
D O I
10.1212/WNL.53.5.988
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: The Migraine Disability Assessment (MIDAS) instrument is a five-item questionnaire developed to measure headache-related disability and improve doctor-patient communication about the functional consequences of migraine. Objectives: To examine the test-retest reliability and internal consistency of the five items and of the overall MIDAS score in population-based samples of migraine sufferers in two countries and to compare consistency across countries. Methods: Using a clinically validated telephone interview, population-based samples of migraine-headache sufferers were identified in the United States (Baltimore, MD) and the United Kingdom (Merton and Sutton, Surrey). Eligible individuals completed the MIDAS questionnaire on two occasions an average of 3 weeks apart. The MIDAS score is derived from five questions about missed time from work and household work (one question each about missed days and days with at least 50% reduced productivity) and missed days of nonwork activities. Results: A total of 97 migraine-headache sufferers from the United States and 100 from the United Kingdom completed the MIDAS questionnaire twice. Mean and median item values and overall MIDAS scores were similar between the United States and the United Kingdom. Test-retest Spearman correlations of individual items ranged from 0.46 to 0.78, No significant differences in item-specific correlations were observed between the United States and United Kingdom. The test-retest Pearson correlation of the MIDAS score (i.e., sum of lost days and reduced-effectiveness days in each domain) was 0.80 in the United States and 0.83 in the United Kingdom. The Cronbach alpha, a measure of internal consistency, was 0.76 in the United States and 0.73 in the United Kingdom. Conclusions: This is the first international population-based study to assess the reliability of a disability-related illness severity score for migraine. The reliability and internal consistency of the Migraine Disability Assessment score are similar to that of a previous questionnaire (Headache Impact Questionnaire), However, the Migraine Disability Assessment score requires fewer questions, is easier to score, and provides intuitively meaningful information on lost days of activity in three domains.
引用
收藏
页码:988 / 994
页数:7
相关论文
共 50 条
  • [21] Assessment of Migraine Disability Using the Migraine Disability Assessment (MIDAS) Questionnaire: A Comparison of Chronic Migraine With Episodic Migraine in young Nigerians
    Adikaibe, Ezeala-Adikaibe B.
    Okafor, H.
    Orjioke, C.
    Aneke, E.
    [J]. HEADACHE, 2016, 56 : 29 - 29
  • [22] Premonitory symptoms and migraine disability assessment (MIDAS) questionnaire
    Sretenovic, S.
    Stanic, A.
    Mitrovic, A.
    [J]. JOURNAL OF HEADACHE AND PAIN, 2014, 15
  • [23] Validity of the migraine disability assessment (MIDAS) score in comparison to a diary-based measure in a population sample of migraine sufferers
    Stewart, WF
    Lipton, RB
    Kolodner, KB
    Sawyer, J
    Lee, CA
    Liberman, JN
    [J]. NEUROLOGY, 1999, 52 (06) : A470 - A470
  • [24] The impact of resilience on headache disability as measured by the Migraine Disability Assessment (MIDAS)
    Hans, Avneet
    Stonnington, Cynthia M.
    Zhang, Nan
    Butterfield, Richard
    Friedman, Deborah I.
    [J]. HEADACHE, 2023, 63 (06): : 743 - 750
  • [25] Validity and reliability of Migraine Disability Assessment (MIDAS) questionnaire in Turkish patients with tension type headache
    Gedikoglu, U
    Ucler, S
    Coskun, O
    Tunc, T
    Emre, U
    Yildiz, H
    Inan, L
    [J]. CEPHALALGIA, 2003, 23 (07) : 632 - 632
  • [26] Validity of the Migraine Disability Assessment (MIDAS) score in comparison to a diary-based measure in a population sample of migraine sufferers
    Stewart, WF
    Lipton, RB
    Kolodner, KB
    Sawyer, J
    Lee, C
    Liberman, JN
    [J]. PAIN, 2000, 88 (01) : 41 - 52
  • [27] Clinical utility of a new instrument assessing migraine disability: The migraine disability assessment (MIDAS) questionnaire
    Sawyer, J
    Edmeads, J
    Lipton, RB
    Stewart, WF
    [J]. NEUROLOGY, 1998, 50 (04) : A433 - A434
  • [28] The Migraine Disability Assessment (MIDAS) as an indicator of resilience in patients with headaches
    Friedman, D., I
    Stonnington, C.
    Hans, A.
    Zhang, N.
    Butterfield, R.
    [J]. HEADACHE, 2022, 62 : 61 - 62
  • [29] Reliability of the French migraine disability assessment (MIDAS) and headache impact test (HIT-6) questionnaires
    Magnoux, E
    Okel, M
    Filipini, D
    Lalonde, J
    Ledoux, S
    Talbot, J
    Zlotnik, G
    Langlois, M
    [J]. HEADACHE, 2005, 45 (06): : 795 - 795
  • [30] Translation, cross-cultural adaptation and reliability of the German version of the migraine disability assessment (MIDAS) questionnaire
    Benz, Thomas
    Lehmann, Susanne
    Gantenbein, Andreas R.
    Sandor, Peter S.
    Stewart, Walter F.
    Elfering, Achim
    Aeschlimann, Andre G.
    Angst, Felix
    [J]. HEALTH AND QUALITY OF LIFE OUTCOMES, 2018, 16